Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hon S Leong
Affiliation
University of Toronto
ORCID
Career Start Year
2002
Papers
67
H Index
31
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36671682
Histological Characterization of Class I HLA Molecules in Whole Umbilical Cord Tissue Towards an Inexhaustible Graft Alternative for Reconstructive Surgery.
Bioengineering (Basel)
2023
34088927
Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.
Sci Rep
2021
33589770
Clinical significance of STEAP1 extracellular vesicles in prostate cancer.
Prostate Cancer Prostatic Dis
2021
32314552
Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
2020
32707733
The Emerging Role of Extracellular Vesicles in the Glioma Microenvironment: Biogenesis and Clinical Relevance.
Cancers (Basel)
2020
33010939
Patient-derived xenografts in surgical oncology: A short research review.
Surgery
2020
30697731
TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
J Pathol
2019
31803361
Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion.
Oncotarget
2019
31327041
A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma.
Abdom Radiol (NY)
2019
31475741
Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.
Prostate
2019
30987640
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.
J Transl Med
2019
30800217
Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases.
Oncotarget
2019
30680751
Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Prostate
2019
30651600
Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis.
Oncogene
2019
30647137
The role of extracellular vesicles in cancer microenvironment and metastasis: myths and challenges.
Biochem Soc Trans
2019
29190494
FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.
Neoplasia
2018
30082495
<i>Drosophila melanogaster</i> as a function-based high-throughput screening model for antinephrolithiasis agents in kidney stone patients.
Dis Model Mech
2018
30112749
Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data Linearity.
Thromb Haemost
2018
30419054
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.
PLoS One
2018
29618619
Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.
Clin Cancer Res
2018
29769644
Translational models of prostate cancer bone metastasis.
Nat Rev Urol
2018
27889376
The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells.
Exp Cell Res
2017
28306507
Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.
Mol Cell
2017
28322574
Editorial Comment for Yoshino et al.: Image-Guided Research in the Clinic to Reduce Surgical Margins.
J Endourol
2017
28419078
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis.
Br J Cancer
2017
28937653
Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Int J Mol Sci
2017
29069723
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer.
Oncotarget
2017
28762517
Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples.
Prostate
2017
28578396
Neonicotinoid-induced pathogen susceptibility is mitigated by Lactobacillus plantarum immune stimulation in a Drosophila melanogaster model.
Sci Rep
2017
27101515
Quantification of cancer cell extravasation in vivo.
Nat Protoc
2016
27756325
Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Mol Cancer
2016
27141054
Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma.
Mol Cell Biol
2016
27553211
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
BMC Cancer
2016
27520820
Probiotic Lactobacillus rhamnosus Reduces Organophosphate Pesticide Absorption and Toxicity to Drosophila melanogaster.
Appl Environ Microbiol
2016
26960793
SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases.
Mol Biol Cell
2016
26771074
Novel Methods of Determining Urinary Calculi Composition: Petrographic Thin Sectioning of Calculi and Nanoscale Flow Cytometry Urinalysis.
Sci Rep
2016
26814433
Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.
Oncotarget
2016
25613050
CORRIGENDUM: Stage of Breast Cancer Progression Influences Cellular Response to Activation of the WNT/Planar Cell Polarity Pathway.
Sci Rep
2015
26544365
[Not Available].
Prog Urol
2015
26068241
Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential.
Nitric Oxide
2015
25964141
Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer.
Prostate Cancer Prostatic Dis
2015
25741641
Evaluating the effectiveness of cancer drug sensitization in vitro and in vivo.
J Vis Exp
2015
24398519
Hypoxia promotes tumor cell motility via RhoA and ROCK1 signaling pathways.
Proc Natl Acad Sci U S A
2014
25204426
Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
Sci Rep
2014
24974076
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.
Mol Oncol
2014
25176655
Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis.
Cell Rep
2014
24733940
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Proc Natl Acad Sci U S A
2014
24879294
Cyclin A2, a novel regulator of EMT.
Cell Mol Life Sci
2014
23525242
KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
Endocrinology
2013
24107191
Re-examining the size/charge paradigm: differing in vivo characteristics of size- and charge-matched mesoporous silica nanoparticles.
J Am Chem Soc
2013
1 - 50 of 67
Column Actions
Search
Recommended Authors
Mengdie Wang
University of Massachusetts Chan School of Medicine
Career Start Year
2016
Number of shared co-authors
0
Sheila Spada
Weill Cornell Medical College
Career Start Year
2014
Number of shared co-authors
0
Mara Gilardi
Institute of Medical Genetics and Pathology.
Career Start Year
2014
Number of shared co-authors
0
Kien Pham
Yale School of Public Health
Career Start Year
2012
Number of shared co-authors
0
Paola A Guerrero
The University of Texas MD Anderson Cancer Center
Career Start Year
2011
Number of shared co-authors
1
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year
2008
Number of shared co-authors
1
Jerry S H Lee
University of Southern California
Career Start Year
2004
Number of shared co-authors
0
Michael G Ozawa
Stanford University School of Medicine
Career Start Year
2004
Number of shared co-authors
0
Trevor D McKee
University Health Network
Career Start Year
2001
Number of shared co-authors
2
Chantal Pauli
University Hospital Zurich
Career Start Year
2001
Number of shared co-authors
1
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year
2000
Number of shared co-authors
2
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year
1999
Number of shared co-authors
0
Dolores Di Vizio
Cedars-Sinai Medical Center
Career Start Year
1997
Number of shared co-authors
2
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year
1996
Number of shared co-authors
0
Jacqueline F Donoghue
University of Melbourne
Career Start Year
1995
Number of shared co-authors
0
Peter Kuhn
University of Tubingen
Career Start Year
1994
Number of shared co-authors
1
Karen H Martin
West Virginia University Cancer Institute, West Virginia University
Career Start Year
1993
Number of shared co-authors
0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year
1989
Number of shared co-authors
1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
1
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
3
Beatrice S Knudsen
University of Utah
Career Start Year
1986
Number of shared co-authors
3
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
0
Wadih Arap
Rutgers Cancer Institute of New Jersey
Career Start Year
1983
Number of shared co-authors
1
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
5
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year
1981
Number of shared co-authors
2
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year
1978
Number of shared co-authors
1
William E Grizzle
University of Alabama at Birmingham
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Fabrice Lucien
Mayo Clinic
Co-authored papers
7
Joseph L Chin
University of Western Ontario
Co-authored papers
3
Paul C Boutros
University of California los angeles
Co-authored papers
3
Aruz Mesci
Juravinski Cancer Centre
Co-authored papers
2
Xiaoyong Huang
Medical College, Yan'an University
Co-authored papers
2
James Koropatnick
Western University, Lawson Health Research Institute
Co-authored papers
2
Stephanie Danielle MacNeil
Schulich School of Medicine and Dentistry, Western University
Co-authored papers
2
Matthew R Lowerison
University of Illinois at Urbana-Champaign
Co-authored papers
2
Alessandro Datti
University of Perugia
Co-authored papers
2
Joe S Mymryk
University of Western Ontario
Co-authored papers
2
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Co-authored papers
2
John Yoo
Schulich School of Medicine & Dentistry, Western University
Co-authored papers
2
Nicole Pinto
School of Public Policy at the University of Calgary
Co-authored papers
2
Anthony C Nichols
University of Western Ontario
Co-authored papers
2
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers
2
Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers
2
Kara M Ruicci
Schulich School of Medicine and Dentistry, Western University
Co-authored papers
2
John W Barrett
University of Western Ontario
Co-authored papers
2
Karlee Searle
McMaster University
Co-authored papers
2
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
1
Samira Taeb
Sunnybrook Research Institute
Co-authored papers
1
Joshua D Stender
University of California San Diego
Co-authored papers
1
Joseph Torchia
Western University
Co-authored papers
1
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers
1
Lakshman Gunaratnam
Schulich School of Medicine and Dentistry, The University of Western Ontario
Co-authored papers
1
Morgan Black
Schulich School of Medicine and Dentistry, Western University
Co-authored papers
1
Alexander D Borowsky
University of California Davis Health
Co-authored papers
1
Fabio M V Rossi
University of British Columbia
Co-authored papers
1
James W Dennis
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University Avenue R988
Co-authored papers
1
Neil E Fleshner
University of Toronto
Co-authored papers
1
1 - 30